Ferroptosis in Osteoarthritis: Current Understanding.

Area of Science:

• Biomedical Science
• Cell Biology
• Pathology

Background:

• Osteoarthritis (OA) is a degenerative joint disease causing cartilage loss, pain, and dysfunction in the elderly.
• OA pathogenesis involves mechanical stress, inflammation, chondrocyte senescence, apoptosis, and metabolic changes.
• Ferroptosis, a regulated cell death marked by lipid peroxidation and mitochondrial dysfunction, is increasingly recognized for its destructive role in OA.

Purpose of the Study:

• To review the current understanding of ferroptosis in osteoarthritis pathogenesis.
• To summarize drugs and compounds targeting ferroptosis for OA treatment.

Main Methods:

• Review of scientific literature on ferroptosis and OA.
• Analysis of mechanisms underlying chondrocyte ferroptosis, including iron accumulation, ROS production, and lipid peroxidation.
• Identification of key ferroptosis regulators like System Xc- and GPX4.
• Summary of preclinical findings for ferroptosis-targeting agents (e.g., DFO, Fer-1) in OA animal models.

Main Results:

• Chondrocyte ferroptosis involves iron accumulation, ROS generation, PUFA-PL peroxidation, and mitochondrial damage.
• System Xc- and GPX4 are critical regulators of ferroptosis in OA.
• Compounds like DFO and Fer-1 have demonstrated efficacy in preventing ferroptosis and mitigating OA progression in animal studies.

Conclusions:

• Ferroptosis plays a destructive role in osteoarthritis pathogenesis.
• Targeting ferroptosis pathways presents a promising therapeutic strategy for OA treatment.